cbdMD (YCBD) EBITDA Margin (2016 - 2025)

cbdMD (YCBD) reported EBITDA Margin of 5.71% for Q4 2025, down 402.0% on a YoY basis from 1.89% in Q4 2024, and up 60.72% sequentially from 14.53% in Q3 2025.

cbdMD (YCBD) EBITDA Margin (2016 - 2025) Analysis & Trends

cbdMD (YCBD) has 10 years of EBITDA Margin data on file, last reported at 5.71% in Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin fell 402.0% year-over-year to 5.71%; the trailing twelve-month figure through Dec 2025 stood at 12.37% (down 49.0% YoY), and the FY2025 full-year result was 11.27%, up 537.0% from the prior year.
  • EBITDA Margin climbed to 5.71% in Q4 2025, from 14.53% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 1.69% in Q4 2024 to a low of 385.51% in Q2 2022.
  • A 5-year average of 77.97% and a median of 31.63% in 2023 frame the typical range for EBITDA Margin.
  • Across the five-year window, EBITDA Margin plunged 32671 bps in 2022 and soared 35571 bps in 2023, its largest moves.
  • Tracing YCBD's EBITDA Margin over 5 years: stood at 255.1% in 2021, then jumped by 75 bps to 64.84% in 2022, then jumped by 69 bps to 19.83% in 2023, then soared by 91 bps to 1.69% in 2024, then sank by 238 bps to 5.71% in 2025.
  • Business Quant data shows YCBD's EBITDA Margin at 5.71% in Q4 2025, 14.53% in Q3 2025, and 19.64% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 16.37%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 36.83%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -38.02%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 41.69%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -2.27%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.74%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.23%
10 cbdMD 438,678.80 -2.95 Mn 3.00 Mn -5.71%

Historic Data

Download Data
DateValue
Dec 31, 2025 -5.71%
Sep 30, 2025 -14.53%
Jun 30, 2025 -19.64%
Mar 31, 2025 -10.23%
Dec 31, 2024 -1.69%
Sep 30, 2024 -6.34%
Jun 30, 2024 -7.38%
Mar 31, 2024 -35.44%
Dec 31, 2023 -19.83%
Sep 30, 2023 -312.64%
Jun 30, 2023 -29.80%
Mar 31, 2023 -22.45%
Dec 31, 2022 -64.84%
Sep 30, 2022 -156.43%
Jun 30, 2022 -385.51%
Mar 31, 2022 -52.03%
Dec 31, 2021 -255.10%
Sep 30, 2021 -67.49%
Jun 30, 2021 -58.80%
Mar 31, 2021 -33.46%